Effects of Latrepirdine on beta amyloid clearance, aggregation and neurodegeneration in Alzheimer�s disease

随着我们日益增长的老龄化人口，阿尔茨海默病(AD)正变得越来越常见，目前还没有任何治疗方法可以阻止疾病的进展。阿尔茨海默病日益增加的医疗费用凸显了开发任何减缓或阻止阿尔茨海默病发病的治疗方法的必要性。通过了解一种最近在第二阶段临床试验中显示出一些希望的药物[拉曲吡丁]的作用机制，将开发出更特异和更有效的相关药物。

Alzheimer's disease (AD) is becoming more common with our growing aged population and currently no treatment exists that halts disease progress. The increasing health costs of AD underscore the need for development of any treatment that will slow or halt AD pathogenesis. By understanding the mechanisms of action of a drug [latrepirdine] that has recently shown some promise in phase II clinical trials, related drugs that are more specific and potent will be developed.